{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:02:14Z","timestamp":1791820934091,"version":"4.3.4"},"reference-count":88,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T00:00:00Z","timestamp":1628640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Migraine Prevention Project of the American Academy of Pain Medicine Foundation"},{"DOI":"10.13039\/100002429","name":"Amgen Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Lilly USA"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>To systematically evaluate the efficacy and effectiveness of percutaneous interventional treatments for prevention of migraine through a qualitative and (when possible) quantitative analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>An expert panel was asked to develop recommendations for the multidisciplinary preventive treatment of migraine, including interventional strategies. The committee conducted a systematic review and (when evidence was sufficient) a meta-analytic review by using the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) criteria and the modified Cochrane Risk of Bias analysis available in the Covidence data management program. Clinical questions addressed adults with migraine who should be offered prevention. Examined outcomes included headache days, acute medication use, and functional impairment. Acute management of migraine was outside the scope of this guideline.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The committee screened 1,195 studies and assessed 352 by full text, yielding 16 randomized controlled trials that met the inclusion criteria.<\/jats:p><\/jats:sec><jats:sec><jats:title>Recommendations and Conclusions<\/jats:title><jats:p>As informed by evidence related to the preselected outcomes, adverse event profile, cost, and values and preferences of patients, onabotulinumtoxinA received a strong recommendation for its use for chronic migraine prevention and a weak recommendation against its use for episodic migraine prevention. Greater occipital nerve blocks received a weak recommendation for their use for chronic migraine prevention. For greater occipital nerve block, steroid received a weak recommendation against its use vs the use of local anesthetic alone. Occipital nerve with supraorbital nerve blocks, sphenopalatine ganglion blocks, cervical spine percutaneous interventions, and implantable stimulation all received weak recommendations for their use for chronic migraine prevention. The committee found insufficient evidence to assess trigger point injections in migraine prevention and highly discouraged the use of intrathecal medication.<\/jats:p><\/jats:sec>","DOI":"10.1093\/pm\/pnab236","type":"journal-article","created":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T11:23:51Z","timestamp":1627903431000},"page":"164-188","source":"Crossref","is-referenced-by-count":28,"title":["Percutaneous Interventional Strategies for Migraine Prevention: A Systematic Review and Practice Guideline"],"prefix":"10.1093","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3182-7030","authenticated-orcid":false,"given":"Meredith","family":"Barad","sequence":"first","affiliation":[{"name":"Department of Anesthesia (Pain Management) and Neurology and Neurological Sciences, Stanford Hospital and Clinics, Stanford, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Ailani","sequence":"additional","affiliation":[{"name":"Department of Neurology, Medstar Georgetown University, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameh M","family":"Hakim","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Intensive Care, and Pain Management, Ain Shams University Faculty of Medicine, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narayan R","family":"Kissoon","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4970-6296","authenticated-orcid":false,"given":"Nathaniel M","family":"Schuster","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, University of California, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,8,11]]},"reference":[{"issue":"1","key":"2022010319344125000_pnab236-B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/0333102417738202","article-title":"Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition","volume":"38","year":"2018","journal-title":"Cephalalgia"},{"issue":"10100","key":"2022010319344125000_pnab236-B2","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016","volume":"390","year":"2017","journal-title":"Lancet"},{"issue":"4","key":"2022010319344125000_pnab236-B3","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ncl.2019.06.001","article-title":"Migraine: Epidemiology, burden, and comorbidity","volume":"37","author":"Burch","year":"2019","journal-title":"Neurol Clin"},{"issue":"5","key":"2022010319344125000_pnab236-B4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1212\/01.wnl.0000252808.97649.21","article-title":"Migraine prevalence, disease burden, and the need for preventive therapy","volume":"68","author":"Lipton","year":"2007","journal-title":"Neurology"},{"issue":"4","key":"2022010319344125000_pnab236-B5","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1526-4610.2007.00757.x","article-title":"Patients\u2019 preference for migraine preventive therapy","volume":"47","author":"Peres","year":"2007","journal-title":"Headache"},{"issue":"4","key":"2022010319344125000_pnab236-B6","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/head.14103","article-title":"Barriers to care in episodic and chronic migraine: Results from the Chronic Migraine Epidemiology and Outcomes Study","volume":"61","author":"Buse","year":"2021","journal-title":"Headache"},{"issue":"6","key":"2022010319344125000_pnab236-B7","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1526-4610.2012.02185.x","article-title":"The 2012 AHS\/AAN guidelines for prevention of episodic migraine: A summary and comparison with other recent clinical practice guidelines","volume":"52","author":"Loder","year":"2012","journal-title":"Headache"},{"issue":"9","key":"2022010319344125000_pnab236-B8","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/j.1468-1331.2009.02748.x","article-title":"EFNS guideline on the drug treatment of migraine\u2014revised report of an EFNS task force","volume":"16","author":"Evers","year":"2009","journal-title":"Eur J Neurol"},{"key":"2022010319344125000_pnab236-B9","first-page":"S1","article-title":"Canadian Headache Society guideline for migraine prophylaxis","volume":"39","author":"Pringsheim","year":"2012","journal-title":"Can J Neurol Sci"},{"issue":"17","key":"2022010319344125000_pnab236-B10","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1212\/WNL.0b013e3182535d20","article-title":"Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society","volume":"78","author":"Silberstein","year":"2012","journal-title":"Neurology"},{"issue":"1","key":"2022010319344125000_pnab236-B11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/head.13456","article-title":"The American Headache Society position statement on integrating new migraine treatments into clinical practice","volume":"59","year":"2019","journal-title":"Headache"},{"key":"2022010319344125000_pnab236-B12"},{"issue":"7650","key":"2022010319344125000_pnab236-B13","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: An emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"2022010319344125000_pnab236-B14","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/head.13375","article-title":"Pharmacologic prevention of migraine: A narrative review of the state of the art in 2018","volume":"58(suppl 3","author":"Loder","year":"2018","journal-title":"Headache"},{"issue":"5","key":"2022010319344125000_pnab236-B15","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1177\/0333102418758283","article-title":"Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults","volume":"38","author":"Tassorelli","year":"2018","journal-title":"Cephalalgia"},{"key":"2022010319344125000_pnab236-B16","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1212\/WNL.56.suppl_1.S20","article-title":"Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability","volume":"56","author":"Stewart","year":"2001","journal-title":"Neurology"},{"issue":"8","key":"2022010319344125000_pnab236-B17","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1023\/A:1026119331193","article-title":"A six-item short-form survey for measuring headache impact: The HIT-6","volume":"12","author":"Kosinski","year":"2003","journal-title":"Qual Life Res"},{"key":"2022010319344125000_pnab236-B18"},{"issue":"7","key":"2022010319344125000_pnab236-B19","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1177\/0333102410364676","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial","volume":"30","author":"Aurora","year":"2010","journal-title":"Cephalalgia"},{"issue":"7","key":"2022010319344125000_pnab236-B20","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1177\/0333102410364677","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial","volume":"30","author":"Diener","year":"2010","journal-title":"Cephalalgia"},{"issue":"15","key":"2022010319344125000_pnab236-B21","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1212\/WNL.0b013e318232ab65","article-title":"OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine","volume":"77","author":"Lipton","year":"2011","journal-title":"Neurology"},{"issue":"9","key":"2022010319344125000_pnab236-B22","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1177\/0333102416655159","article-title":"Short-term effects of greater occipital nerve blocks in chronic migraine: A double-blind, randomised, placebo-controlled clinical trial","volume":"37","author":"Cuadrado","year":"2017","journal-title":"Cephalalgia"},{"issue":"11","key":"2022010319344125000_pnab236-B23","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1177\/0333102414561872","article-title":"Occipital nerve block for the short-term preventive treatment of migraine: A randomized, double-blinded, placebo-controlled study","volume":"35","author":"Dilli","year":"2015","journal-title":"Cephalalgia"},{"issue":"2","key":"2022010319344125000_pnab236-B24","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/ane.12716","article-title":"The efficacy of greater occipital nerve blockade in chronic migraine: A placebo-controlled study","volume":"136","author":"Gul","year":"2017","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"2022010319344125000_pnab236-B25","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/ane.12393","article-title":"Greater occipital nerve blockade for the treatment of chronic migraine: A randomized, multicenter, double-blind, and placebo-controlled study","volume":"132","author":"Inan","year":"2015","journal-title":"Acta Neurol Scand"},{"issue":"6","key":"2022010319344125000_pnab236-B26","doi-asserted-by":"crossref","first-page":"209","DOI":"10.5539\/gjhs.v6n6p209","article-title":"Preventive effect of greater occipital nerve block on severity and frequency of migraine headache","volume":"6","author":"Kashipazha","year":"2014","journal-title":"Glob J Health Sci"},{"issue":"4","key":"2022010319344125000_pnab236-B27","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/jnnp.2007.124420","article-title":"Greater occipital nerve block using local anaesthetics alone or with triamcinolone for transformed migraine: A randomised comparative study","volume":"79","author":"Ashkenazi","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"2022010319344125000_pnab236-B28","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1080\/03007995.2018.1532403","article-title":"Greater occipital and supraorbital nerve blockade for the preventive treatment of migraine: A single-blind, randomized, placebo-controlled study","volume":"35","author":"\u00d6zer","year":"2019","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"2022010319344125000_pnab236-B29","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/head.12546","article-title":"Long-term efficacy of a double-blind, placebo-controlled, randomized study for repetitive sphenopalatine blockade with bupivacaine vs. saline with the Tx360 device for treatment of chronic migraine","volume":"55","author":"Cady","year":"2015","journal-title":"Headache"},{"key":"2022010319344125000_pnab236-B30","first-page":"1","article-title":"Efficacy of pulsed radiofrequency on cervical 2-3 posterior medial branches in treating chronic migraine: a randomized, controlled, and double-blind trial","volume":"2015","author":"Yang","year":"2015","journal-title":"Evid Based Complement Alternat Med"},{"issue":"3","key":"2022010319344125000_pnab236-B31","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/0333102410381142","article-title":"Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study","volume":"31","author":"Saper","year":"2011","journal-title":"Cephalalgia"},{"issue":"3;5","key":"2022010319344125000_pnab236-B32","doi-asserted-by":"crossref","first-page":"245","DOI":"10.36076\/ppj.2012\/15\/245","article-title":"Occipital nerve stimulation for chronic migraine: A randomized trial","volume":"3;15","author":"Serra","year":"2012","journal-title":"Pain Physician"},{"issue":"16","key":"2022010319344125000_pnab236-B33","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/0333102412462642","article-title":"Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: Results from a randomized, multicenter, double-blinded, controlled study","volume":"32","author":"Silberstein","year":"2012","journal-title":"Cephalalgia"},{"issue":"1","key":"2022010319344125000_pnab236-B34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/0333102414534082","article-title":"Occipital nerve stimulation for chronic migraine: A randomized trial on subthreshold stimulation","volume":"35","author":"Slotty","year":"2015","journal-title":"Cephalalgia"},{"key":"2022010319344125000_pnab236-B35","first-page":"9","article-title":"The International Classification of Headache Disorders: 2nd edition","volume":"24(suppl 1","year":"2004","journal-title":"Cephalalgia"},{"issue":"9","key":"2022010319344125000_pnab236-B36","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/0333102413485658","article-title":"The International Classification of Headache Disorders, 3rd edition (beta version)","volume":"33","year":"2013","journal-title":"Cephalalgia"},{"issue":"4","key":"2022010319344125000_pnab236-B37","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1212\/WNL.47.4.871","article-title":"Classification of daily and near-daily headaches: Field trial of revised IHS criteria","volume":"47","author":"Silberstein","year":"1996","journal-title":"Neurology"},{"issue":"7652","key":"2022010319344125000_pnab236-B38","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/bmj.39493.646875.AE","article-title":"Going from evidence to recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"1","key":"2022010319344125000_pnab236-B39","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s10194-017-0813-3","article-title":"Patients\u2019 preferences for headache acute and preventive treatment","volume":"18","author":"Mitsikostas","year":"2017","journal-title":"J Headache Pain"},{"issue":"5","key":"2022010319344125000_pnab236-B40","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/head.13498","article-title":"Patient preferences for preventive migraine treatments: A discrete-choice experiment","volume":"59","author":"Mansfield","year":"2019","journal-title":"Headache"},{"issue":"1","key":"2022010319344125000_pnab236-B41","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/head.12458","article-title":"A double-blind, placebo-controlled study of repetitive transnasal sphenopalatine ganglion blockade with tx360((R)) as acute treatment for chronic migraine","volume":"55","author":"Cady","year":"2015","journal-title":"Headache"},{"issue":"6","key":"2022010319344125000_pnab236-B42","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1468-2982.2007.01315.x","article-title":"A multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of episodic migraine headaches","volume":"27","author":"Relja","year":"2007","journal-title":"Cephalalgia"},{"issue":"4","key":"2022010319344125000_pnab236-B43","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1526-4610.2006.00624.x","article-title":"Botulinum toxin type a prophylactic treatment of episodic migraine: A randomized, double-blind, placebo-controlled exploratory study","volume":"47","author":"Aurora","year":"2007","journal-title":"Headache"},{"issue":"6","key":"2022010319344125000_pnab236-B44","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1526-4610.2010.01678.x","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: Pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program","volume":"50","author":"Dodick","year":"2010","journal-title":"Headache"},{"key":"2022010319344125000_pnab236-B45","volume-title":"The HIT-6\u2122: A User's Guide","author":"Bayliss","year":"2002"},{"issue":"1","key":"2022010319344125000_pnab236-B46","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/ane.12171","article-title":"OnabotulinumtoxinA for chronic migraine: Efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program","volume":"129","author":"Aurora","year":"2014","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"2022010319344125000_pnab236-B47","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/brain\/awz052","article-title":"Acute withdrawal and botulinum toxin A in chronic migraine with medication overuse: A double-blind randomized controlled trial","volume":"142","author":"Pijpers","year":"2019","journal-title":"Brain"},{"issue":"1","key":"2022010319344125000_pnab236-B48","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s10194-018-0840-8","article-title":"Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study","volume":"19","author":"Blumenfeld","year":"2018","journal-title":"J Headache Pain"},{"issue":"1","key":"2022010319344125000_pnab236-B49","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s10194-018-0921-8","article-title":"Guideline on the use of onabotulinumtoxinA in chronic migraine: A consensus statement from the European Headache Federation","volume":"19","author":"Bendtsen","year":"2018","journal-title":"J Headache Pain"},{"key":"2022010319344125000_pnab236-B50","year":"2012"},{"key":"2022010319344125000_pnab236-B51","year":"2014"},{"issue":"10","key":"2022010319344125000_pnab236-B52","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1111\/head.13653","article-title":"FORWARD Study: Evaluating the comparative effectiveness of OnabotulinumtoxinA and topiramate for headache prevention in adults with chronic migraine","volume":"59","author":"Rothrock","year":"2019","journal-title":"Headache"},{"issue":"5","key":"2022010319344125000_pnab236-B53","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/0333102416678382","article-title":"Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysis","volume":"37","author":"Hepp","year":"2017","journal-title":"Cephalalgia"},{"issue":"2","key":"2022010319344125000_pnab236-B54","doi-asserted-by":"crossref","first-page":"97","DOI":"10.5152\/NSN.2018.10290","article-title":"Comparison of single and repeated blockade of the greater occipital nerve in migraine treatment","volume":"35","author":"Karadas","year":"2018","journal-title":"Neurological Sciences and Neurophysiology"},{"issue":"2","key":"2022010319344125000_pnab236-B55","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"J Pain"},{"issue":"2","key":"2022010319344125000_pnab236-B56","doi-asserted-by":"crossref","first-page":"153","DOI":"10.36076\/ppj\/2015.18.153","article-title":"Ultrasound-guided greater occipital nerve block: An efficient technique in chronic refractory migraine without aura?","volume":"18","author":"Palamar","year":"2015","journal-title":"Pain Physician"},{"issue":"11","key":"2022010319344125000_pnab236-B57","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.ajem.2017.08.027","article-title":"Influence of greater occipital nerve block on pain severity in migraine patients: A systematic review and meta-analysis","volume":"35","author":"Tang","year":"2017","journal-title":"Am J Emerg Med"},{"key":"2022010319344125000_pnab236-B58","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.clineuro.2017.12.026","article-title":"The efficacy of greater occipital nerve block for the treatment of migraine: A systematic review and meta-analysis","volume":"165","author":"Zhang","year":"2018","journal-title":"Clin Neurol Neurosurg"},{"issue":"4","key":"2022010319344125000_pnab236-B59","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.bja.2019.01.004","article-title":"Dexamethasone as an adjuvant for peripheral nerve blockade: A randomised, triple-blinded crossover study in volunteers","volume":"122","author":"Marhofer","year":"2019","journal-title":"Br J Anaesth"},{"issue":"1","key":"2022010319344125000_pnab236-B60","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/anae.12823","article-title":"A systematic review and meta-analysis of perineural dexamethasone for peripheral nerve blocks","volume":"70","author":"Albrecht","year":"2015","journal-title":"Anaesthesia"},{"issue":"11","key":"2022010319344125000_pnab236-B61","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/EJA.0000000000000248","article-title":"Combination of dexamethasone and local anaesthetic solution in peripheral nerve blocks: A meta-analysis of randomised controlled trials","volume":"32","author":"Huynh","year":"2015","journal-title":"Eur J Anaesthesiol"},{"issue":"3","key":"2022010319344125000_pnab236-B62","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/AAP.0000000000000571","article-title":"Perineural versus intravenous dexamethasone as an adjuvant for peripheral nerve blocks: A systematic review and meta-analysis","volume":"42","author":"Chong","year":"2017","journal-title":"Reg Anesth Pain Med"},{"issue":"1\u20132","key":"2022010319344125000_pnab236-B63","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.pain.2006.01.016","article-title":"Greater occipital nerve injection in primary headache syndromes\u2014prolonged effects from a single injection","volume":"122","author":"Afridi","year":"2006","journal-title":"Pain"},{"issue":"4","key":"2022010319344125000_pnab236-B64","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/pmrj.12042","article-title":"Systemic absorption and side effects of locally injected glucocorticoids","volume":"11","author":"Stout","year":"2019","journal-title":"Pm R"},{"issue":"1","key":"2022010319344125000_pnab236-B65","first-page":"183","article-title":"Cutaneous atrophy after corticosteroid injection","volume":"33","author":"Louis","year":"1986","journal-title":"Am Fam Physician"},{"key":"2022010319344125000_pnab236-B66","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2147\/JPR.S60925","article-title":"Incidence of neuropathic pain after radiofrequency denervation of the third occipital nerve","volume":"7","author":"Gazelka","year":"2014","journal-title":"J Pain Res"},{"issue":"2","key":"2022010319344125000_pnab236-B67","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1533-2500.2006.00068.x","article-title":"Occipital nerve blockade for cervicogenic headache: A double-blind randomized controlled clinical trial","volume":"6","author":"Naja","year":"2006","journal-title":"Pain Pract"},{"issue":"1-2","key":"2022010319344125000_pnab236-B68","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.pain.2005.07.015","article-title":"Suboccipital injection with a mixture of rapid- and long-acting steroids in cluster headache: A double-blind placebo-controlled study","volume":"118","author":"Ambrosini","year":"2005","journal-title":"Pain"},{"issue":"12","key":"2022010319344125000_pnab236-B69","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1097\/j.pain.0000000000000373","article-title":"Randomized, double-blind, comparative-effectiveness study comparing pulsed radiofrequency to steroid injections for occipital neuralgia or migraine with occipital nerve tenderness","volume":"156","author":"Cohen","year":"2015","journal-title":"Pain"},{"issue":"1","key":"2022010319344125000_pnab236-B70","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/jnnp.74.1.88","article-title":"Radiofrequency neurotomy for the treatment of third occipital headache","volume":"74","author":"Govind","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"2022010319344125000_pnab236-B71","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1526-4637.2006.00201.x","article-title":"Cervical zygapophysial joint pain maps","volume":"8","author":"Cooper","year":"2007","journal-title":"Pain Med"},{"issue":"5","key":"2022010319344125000_pnab236-B72","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/papr.12504","article-title":"Safety and efficacy of occipital nerves stimulation for the treatment of chronic migraines: Randomized, double-blind controlled single-center experience","volume":"17","author":"Mekhail","year":"2017","journal-title":". Pain Pract"},{"issue":"4","key":"2022010319344125000_pnab236-B73","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1177\/0333102414543331","article-title":"Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: Long-term results from a randomized, multicenter, double-blinded, controlled study","volume":"35","author":"Dodick","year":"2015","journal-title":"Cephalalgia"},{"issue":"2","key":"2022010319344125000_pnab236-B74","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/ner.12843","article-title":"Spinal cord stimulation infection rate and risk factors: Results from a United States Payer Database","volume":"22","author":"Falowski","year":"2019","journal-title":"Neuromodulation"},{"issue":"6","key":"2022010319344125000_pnab236-B75","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/ner.12609","article-title":"Spinal cord stimulator implant infection rates and risk factors: A multicenter retrospective study","volume":"20","author":"Hoelzer","year":"2017","journal-title":"Neuromodulation"},{"key":"2022010319344125000_pnab236-B76","article-title":"PRISM study: Occipital nerve stimulation for treatment-refractory migraine","volume":"29","author":"Lipton","year":"2009","journal-title":"Cephalalgia"},{"key":"2022010319344125000_pnab236-B77"},{"key":"2022010319344125000_pnab236-B78"},{"issue":"1","key":"2022010319344125000_pnab236-B79","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s10194-017-0787-1","article-title":"Fluctuations in episodic and chronic migraine status over the course of 1 year: Implications for diagnosis, treatment and clinical trial design","volume":"18","author":"Serrano","year":"2017","journal-title":"J Headache Pain"},{"issue":"16","key":"2022010319344125000_pnab236-B80","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1001\/jama.2012.505","article-title":"Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: A meta-analysis","volume":"307","author":"Jackson","year":"2012","journal-title":"JAMA"},{"issue":"7","key":"2022010319344125000_pnab236-B81","doi-asserted-by":"crossref","first-page":"e027953","DOI":"10.1136\/bmjopen-2018-027953","article-title":"Cochrane systematic review and meta-analysis of botulinum toxin for the prevention of migraine","volume":"9","author":"Herd","year":"2019","journal-title":"BMJ Open"},{"issue":"3","key":"2022010319344125000_pnab236-B82","doi-asserted-by":"crossref","first-page":"e0116786","DOI":"10.1371\/journal.pone.0116786","article-title":"Occipital nerve stimulation for chronic migraine\u2013A systematic review and meta-analysis","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"2022010319344125000_pnab236-B83","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s10194-020-01204-4","article-title":"Neuromodulation techniques for acute and preventive migraine treatment: A systematic review and meta-analysis of randomized controlled trials","volume":"21","author":"Moisset","year":"2020","journal-title":"J Headache Pain"},{"issue":"3","key":"2022010319344125000_pnab236-B84","doi-asserted-by":"crossref","first-page":"e687","DOI":"10.1097\/PR9.0000000000000687","article-title":"Unique aspects of clinical trials of invasive therapies for chronic pain","volume":"4","author":"Cohen","year":"2019","journal-title":"Pain Rep"},{"issue":"7","key":"2022010319344125000_pnab236-B85","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jclinepi.2014.12.016","article-title":"Head-to-head randomized trials are mostly industry sponsored and almost always favor the industry sponsor","volume":"68","author":"Flacco","year":"2015","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"2022010319344125000_pnab236-B86","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.spinee.2015.01.027","article-title":"Spine device clinical trials: Design and sponsorship","volume":"15","author":"Cher","year":"2015","journal-title":"Spine J"},{"issue":"1","key":"2022010319344125000_pnab236-B87","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1533-2500.2007.00104.x","article-title":"Placebo theory and its implications for research and clinical practice: A review of the recent literature","volume":"7","author":"Koshi","year":"2007","journal-title":"Pain Pract"},{"key":"2022010319344125000_pnab236-B88","volume-title":"Clinical Practice Guideline Process Manual, 2011 Ed","year":"2011"}],"container-title":["Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/painmedicine\/advance-article-pdf\/doi\/10.1093\/pm\/pnab236\/40256751\/pnab236.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/painmedicine\/article-pdf\/23\/1\/164\/42040360\/pnab236.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/painmedicine\/article-pdf\/23\/1\/164\/42040360\/pnab236.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T19:46:00Z","timestamp":1699299960000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/painmedicine\/article\/23\/1\/164\/6348178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,11]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,8,11]]},"published-print":{"date-parts":[[2022,1,3]]}},"URL":"https:\/\/doi.org\/10.1093\/pm\/pnab236","relation":{},"ISSN":["1526-2375","1526-4637"],"issn-type":[{"value":"1526-2375","type":"print"},{"value":"1526-4637","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,1,1]]},"published":{"date-parts":[[2021,8,11]]}}}